Skip to Main Content
Don't have an account? Create Account

Our View: 340B Benefits Vulnerable Patients, Essential Hospitals, Taxpayers

The bipartisan 340B Drug Pricing Program has supported affordable drugs and services to vulnerable patients since 1992 – at nearly no cost to taxpayers. But pending regulations would dramatically narrow access to the program, hurting patients and putting entire communities at risk of losing vital services, such as trauma care and emergency preparedness.

Read Our View: 340B Benefits Vulnerable Patients, Essential Hospitals, Taxpayers

View our infographic: 340B Guidance: When a Patient is Not a Patient

Share

About the Author

Dedicated staff at America's Essential Hospitals work together to produce high-quality, reliable content. Please view the about section for more details about staff.

Previous Next
Close
Test Caption
Test Description goes like this